title: Is sampling really effective in staging non-small cell lung cancer? A prospective study.
abstract: Is sampling really effective in staging non-small cell lung cancer? The aim of the study was to assess if systematic nodal dissection is necessary in order to stage non-small cell lung cancer correctly or whether mediastinal lymph node sampling can be used and whether in selected cases it could replace systematic nodal dissection for the treatment of lung cancer. A prospective study was conducted in 94 patients affected by clinically resectable non-small cell lung cancer (stages I-IIIB) who were surgically treated by the same team of surgeons. During surgery mediastinal lymph node sampling was done first and then another surgeon completed the systematic nodal dissection and performed the lung resection. One hundred and ninety-three mediastinal nodal stations were investigated using the American Thoracic Society lymph node map to identify them. On analysing the 193 mediastinal nodal stations investigated, it emerged that in 181 cases (94%) mediastinal lymph node sampling and systematic nodal dissection yielded the same histopathological findings, whereas in 12 cases (6%) there was no agreement between the two techniques. The negative predictive value of mediastinal lymph node sampling was 92.8% (103/111). The results of the study show no statistical difference between mediastinal lymph node sampling and systematic nodal dissection in staging non-small cell lung cancer. However, it is possible that in a limited percentage of cases a nodal station could be understaged and thus the surgical resection could prove incomplete if mediastinal lymph node sampling alone is performed. Moreover, in those cases where mediastinal lymph node sampling detects N2 disease and systematic nodal dissection has not been completed, the intervention cannot be considered radical.
authors.affiliation: Unità Operativa di Chirurgia Toracica, Ospedale Civile Maggiore, Verona.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Magnanelli
authors.forename: Paolo
authors.initials: P
authors.lastname: Scanagatta
authors.forename: Cristiano
authors.initials: C
authors.lastname: Benato
authors.forename: Alberto
authors.initials: A
authors.lastname: Terzi
authors.forename: Alessando
authors.initials: A
authors.lastname: Lonardoni
authors.forename: Giovanni
authors.initials: G
authors.lastname: Falezza
authors.forename: Gaetano
authors.initials: G
authors.lastname: Furlan
authors.forename: Francesco
authors.initials: F
authors.lastname: Calabrò
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology* / Q000556:secondary* / Q000601:surgery; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology* / Q000601:surgery; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D008482:Mediastinum; D009367:Neoplasm Staging; D011446:Prospective Studies